Planned Parenthood of Greater Ohio Celebrates Continued Access to Medication Abortion
For Immediate Release: June 13, 2024 (Updated: June 13, 2024, 3:59 p.m.)
MEDIA CONTACT: Hannah Gavin, West End Strategy Team, 202-765-4290, [email protected]
COLUMBUS, OHIO – Today’s decision by the U.S. Supreme Court in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration ensures that the regimen for medication abortion remains unchanged. In response to the Court’s decision, Erica Wilson-Domer, President & CEO of Planned Parenthood of Greater Ohio, released the following statement:
"More than 5 million people have used mifepristone since the FDA approved it more than 20 years ago. As the Supreme Court recognized in its unanimous decision rejecting the standing of the case, attacks on mifepristone and medication abortion are driven by disingenuous and cynical actors who prioritize their political views over ensuring access to life-saving healthcare.
Patients deserve to access the medication they need, and providers should be able to care for their patients without unnecessary interference. Abortion, including medication abortion, is legal and constitutionally protected in Ohio. Planned Parenthood of Greater Ohio will continue to ensure patients can access the abortion method of their choice with as few barriers as possible. We are committed to following evidence-based standards to provide safe, high-quality abortion care and information to patients who come to us for care."
If you are interested in speaking with Erica Wilson-Domer of Planned Parenthood of Greater Ohio, please contact Hannah Gavin at 202-765-4290 or [email protected].